Michael Rome
Direttore/Membro del Consiglio presso Remix Therapeutics, Inc.
Posizioni attive di Michael Rome
Società | Posizione | Inizio | Fine |
---|---|---|---|
Foresite Life Sciences Corp.
Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2021 | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Michael Rome
Precedenti posizioni note di Michael Rome
Società | Posizione | Inizio | Fine |
---|---|---|---|
KINNATE BIOPHARMA INC. | Direttore/Membro del Consiglio | 01/12/2019 | 03/04/2024 |
Independent Dir/Board Member | 01/12/2019 | 03/04/2024 | |
THESEUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/01/2021 | 14/02/2024 |
Independent Dir/Board Member | 01/01/2021 | 14/02/2024 | |
FS DEVELOPMENT CORP. | Direttore/Membro del Consiglio | 01/06/2020 | 01/02/2021 |
Corporate Officer/Principal | 01/06/2020 | 01/02/2021 | |
PHARVARIS N.V. | Direttore/Membro del Consiglio | 01/01/2019 | 31/12/2020 |
PARDES BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/08/2020 | - |
Corporate Officer/Principal | 01/08/2020 | - |
Formazione di Michael Rome
University of California, Los Angeles | Undergraduate Degree |
California Institute of Technology | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Paesi Bassi | 2 |
Posizioni
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Settori
Health Technology | 5 |
Finance | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PHARVARIS N.V. | Health Technology |
Aziende private | 6 |
---|---|
FS Development Corp.
FS Development Corp. Financial ConglomeratesFinance FS Development Corp. operates as a blank check company. It is for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Jim Tananbaum in June 2020 and is headquartered in San Francisco, CA. | Finance |
Kinnate Biopharma, Inc.
Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
FS Development Corp. II
FS Development Corp. II Financial ConglomeratesFinance FS Development Corp. II is a blank check company, which formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more entities. The company was founded by James B. Tananbaum on August 21, 2020 and is headquartered in Larkspur, CA. | Finance |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
Foresite Life Sciences Corp.
Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael Rome
- Esperienza